Follow the 지투지바이오 share price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares trade on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 지투지바이오 has published 24 insider filings. Market capitalisation: €500.5bn. The latest transaction was filed on 22 May 2026 (Purchase). Among the most active insiders: 이희용. All data is free.
24
Insider Decl.
n/a
Thresholds
€126,583
24 ops.
Buy Volume
n/a
n/a
Sell Volume
30Σ signal
Buys €126,583n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
